Clinical Trial Update: Romiplostim in Chemotherapy-Induced Thrombocytopenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for romiplostim in chemotherapy-induced thrombocytopenia associated with solid malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia
• Solid Malignancy

Drugs mentioned

• Romiplostim (romiplostim)

Snippet

Sponsor: Ain Shams University | Conditions: Chemotherapy-induced Thrombocytopenia, Solid Malignancy | Phase 3 | Status: UNKNOWN